n be isolated from their bone marrow, and we observed that repair could be achieved by injecting a person's own stem cells into the bad discs," said Prologo. "After attaching an imaging agent to the injected cells, we were able to prove accurate delivery and containment of those cells at the desired site of action. And, we are now performing the first in human trials of this technique," he added.
"The use of interventional radiology for the delivery of regenerative therapies, such as stem cells, can lead to other minimally invasive procedures associated with potential symptom relief and decreased cost and complications associated with open surgery," Prologo stated. "This research may serve as a precedent for a wide variety of stem cell applications in humans through interventional radiology," he said.
More information about the Society of Interventional Radiology, interventional radiologists and minimally invasive treatments can be found online at www.SIRweb.org.
Abstract 2: "Percutaneous Image-guided Transplantation of Human Mesenchymal Stem Cells for the Treatment of Symptomatic Degenerated Intervertebral Discs," J.D. Prologo, department of radiology, vascular and interventional radiology; D. Hart, department of neurosurgery; Z. Love, Z. Lee, department of radiology, all University Hospitals Case Medical Center, Cleveland, Ohio; D. Corn, A. Sattar, L.W. Yuan, N. Tenley, department of biomedical engineering, Case Western Reserve University, Cleveland, Ohio.
Abstract 10: "Bariatric Gastric Arterial Embolization for Modulation of Systemic Ghrelin Levels in a Porcine Model: Endoscopic and Histopathologic Correlation," B.E. Paxton, J. Crow, C. Alley, B. Balmadrid, S. Stinnett, C.G. Keith, R. Kankotia, C.Y. Kim, Duke University Medical Center, Durham, N.C.; A. Arepally, Piedmont Healthcare, Atlanta.
Abstract No. 146: "Gastric Arterial Embolization With X-Ray-vis
'/>"/>
SOURCE Society of Interventional Radiology Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine technology :1.
TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate2.
Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I3.
Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain4.
ABSTRAL® (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S.5.
American Pain Foundation Launches New Educational Campaign, "Explain Your Pain," to Help Hispanic Americans Better Understand Chronic Pain and Pain Management6.
Adding "Insult to Injury" - Occasional Constipation Can Be a Troubling Side Effect for Baby Boomers Taking Medication for Pain, Heartburn, Depression and More7.
The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management8.
ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx9.
DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study10.
Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health11.
Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects